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Poison CarefullyGenomic and biochemical analyses reveal that two independently evolved
serine protease venoms in mammals and lizards have converged on nearly
identical protein structures. Likewise, in two groups of frog, an identical toxin,
caerulein, has arisen repeatedly from unique genes in those lineages.Edmund D. Brodie, III
Are the outcomes of evolution
foreseeable destinations on the journey
of adaptation? Or are Darwin’s ‘‘endless
forms most beautiful’’ just haphazard
stops along roads to nowhere in
particular? Adaptation is driven by an
engine of natural selection continually
preserving the forms with higher fitness,
but ultimately that engine is fueled with
random mutations. The engine cannot
push evolution in a direction that
does not arise by chance, and so the
dogmatic view of evolution is one of
unpredictability. Two recent papers in
Current Biology about the genetic and
biochemical basis of venoms and toxins
challenge this dogmatic preeminence
of chance in determining evolutionary
outcomes [1,2].
Is this perspective of ruling
contingency fair? Evolutionary
convergence stands as one of the most
cited lines of evidence for the power
of natural selection. Countless cases
of taxa that have evolved similar
features suggest that there is some
predictability to adaptation, at least
in a general sense. Anolis lizards ofthe Caribbean, for instance, have
repeatedly radiated from common
ancestors to fill similar ecological
niches with associated behavior and
body plans [3]. Different light sensitive
opsin proteins have arisen in bacteria
and metazoans to fulfill comparable
functions with different chemical
structures [4]. Plants of the cactus
and euphorb lineages have arrived at
confusingly similar shapes, defenses,
and stem based photosynthesis to
inhabit xeric habitats [5]. The list goes
on and on.
Most examples of convergence,
however, describe similarities of
general function and performance.
From the outside, convergent
adaptations appear alike, but in the
few cases where their mechanistic
bases have been revealed, we typically
see that evolution has built them in
different ways. Bat wings and bird
wings both evolved from tetrapod
forelimbs, but bats support their
wing membrane across the expanded
digits (‘fingers’), whereas birds have
reduced digits and a flight surface
extending off the arm and hand
bones. The devil may not be in thedetails, but contingency certainly
seems to be.
New molecular and genomic
evidence confronts this view across
wide phylogenetic divides. In a recent
paper in Current Biology [1] comparing
insectivorous mammals and lizards
(Figure 1), we learn that these disparate
vertebrate lineages have arrived at
nearly identical venom proteins
modified from serine proteases.
Natural selection appears to have
driven the proteins to the same
fundamental structures as determined
by the biochemical properties that
determine enzyme activity. In a second
paper in this issue of Current Biology
[2], phylogenetic analyses of genomic
data reveal that an apparently identical
defensive compound, caerulein, found
in two distantly related frog species has
evolved twice from two independent
genetic starting points.
Despite their wide distribution across
almost all groups of animals, venoms
are only known from a few mammals,
including shrews and the insectivore
solendon. Named for a genus of North
American shrews (Blarina), blarinatoxin
(BLTX) is a serine protease that is
clearly related to kallikrein-1 in
structure. BLTX is venomous to the
prey of shrews because it has high
catalytic activity compared to other
serine proteases. This elevated
catalysis consequently floods the
circulatory system with bradykinin,
resulting in paralysis and death.
Tracking this increased catalysis as
the source of toxicity, Aminetzach
Figure 1. Evolutionary convergence of toxic compounds.
The frogs Litoria caerulea (A), in defensive posture, and Xenopus laevis (B) produce structur-
ally identical caerulein toxin that has evolved independently from different genes. The serine
protease venoms of shrews (Blarina sp.) (C) and beaded lizards (Heloderma horridum) (D)
have converged on a common protein structure that results in toxic levels of enzyme activity.
(Photos: E.D. Brodie, Jr.)
Dispatch
R153and colleagues [1] were able to predict
and test structural changes to kallikrein
that would be likely to modify a
digestive enzyme into one with toxic
effects.
Using molecular dynamic
simulations, the team determined two
probable characteristics of BLTX that
were likely to increase enzyme activity
and that differed from more harmless
kallikrein relatives. Flexibility of the
protein would allow rapid
conformational changes and increase
binding to the active site of the enzyme.
As predicted, BLTX differed from other
shrew salivary proteins and human
kallikrein in the length and polarity of
the loops in the active site generating a
more flexible active surface. Secondly,
a contrast in charge between the active
site and surrounding surface is
expected to increase enzyme activity.
BLTX was found to have a uniquely
positively charged surface surrounding
a negatively charged active site. Thus,
the BLTX protein matches neatly the
predicted three-dimensional structure
of a toxic serine protease. These lines
of evidence alone suggest that the
specific modifications of a protein
to acquire toxicity are somewhat
predictable.
What is most amazing about the
structural evolution of BLTX, however,
is that it is mirrored almost perfectly by
another venom in a lineage of predators
separated by at least 300 million years
of evolution. The new world
helodermatid lizards (gila monsters and
beaded lizards) also possess a venom,
GTX, derived from kallikrein-related
enzymes. Like BLTX, its toxicity
obtains from increased catalytic
activity and a consequent deluge of
bradykinin in the circulatory system
of the prey. When Aminetzach and
colleagues [1] examined the structure
of GTX, they found remarkably identical
modifications from lizard serine
proteases. Just like BLTX, GTX had an
insertion of 21 base pairs lengthening
the critical loop 1 of the protein and
providing increased flexibility. Other
substitutions generate a hydrophobic
and positively charged loop 1 that
results in a charge contrast in the area
of the negatively charged active site
comparable to that found in BLTX.
Notably, no similar changes were found
in any of the 24 other kallikrein-like
proteins that were studied.
On the other side of the ecological
road, innumerable prey species have
evolved toxins to defend againstpredators. Caerulein was originally
identified from the skin of an Australian
frog (Litoria caerulea) [6], and is a
relatively nasty toxin that disrupts
the digestive system by binding to
receptors of gastrin and
cholecystokinin (cck), leading to
gastrointestinal distresses, drop in
blood pressure and inhibition of
feeding. Caerulein has since been
identified from a number of frog
species, and was logically assumed
to result from a single evolutionary
origin of the toxin early in the
divergence of frogs.
A deeper genomic analysis
performed by Roelants and colleagues
[2] reveals that caerulein has not only
independently evolved within frogs,
but also has evolved from unique
and independent genetic precursors.
Caerulein in Litoria derived from
changes to the gastrin gene, while
caerulein in the African clawed frog,
Xenopus laevis, arose from a recent
duplication (and subsequent
modification) of the cck gene in that
lineage. Both gastrin and cck genes are
found throughout vertebrates, usually
on different chromosomes, arising from
a duplication event deep in vertebrate
phylogeny approximately 500 million
years ago. Patterns of synteny between
cck/gastrin and other gene pairs
support the deep duplication event.Caerulein was a relative latecomer to
the evolutionary path of these lineages.
The signature of strong directional
selection is still evident in cck-derived
caerulein, but not in the gastrin-derived
group. Expression of cck/gastrin in
the skin evolved only recently and only
in those taxa that evolved caerulein.
Moreover, even the ecological contexts
of selection for caerulein toxicity in
these groups are different: Xenopus
(cck-derived) has a fully aquatic
lifestyle, while Litoria (gastrin-derived)
has a terrestrial habit. The phylogenetic
data thus clearly point to a compound
that, while apparently identical in
protein structure, emerged through two
distinct evolutionary roads that began
from different genetic starting points.
Taken together, these studies
suggest a remarkable predictability
of the biochemical details of evolution.
Venoms and toxins may be somewhat
unique in this sense because their
molecular form so directly determines
their function [7]. Although evolutionary
convergence now is widely recognized
at the molecular level, most examples
involve common changes to the same
gene in different species, such as
substitutions that confer resistance to
natural or anthropogenic toxins [8,9].
The extraordinary insight provided by
these new results is that evolution
sometimes starts from different genes
Current Biology Vol 20 No 4
R154and still arrives at the same place on
the adaptive road.
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SynthesisPhosphatidylinositol (4,5) bisphosphate is a lipid second messenger that
controls diverse cellular processes. Phosphatidylinositolphosphate-5-kinases
synthesise this lipid at the plasma membrane, although it is not clear how the
localisation of these kinases is controlled. A recent study suggests that the
intrinsic surface charge of the plasma membrane may be an important factor.Nullin Divecha
Different permutations of
phosphorylation of the 3, 4 or 5 position
of the inositol head group of
phosphatidylinositol generates seven
different phosphoinositides that form
the basis of a ubiquitous membrane-
associated signalling system [1].
There are over eighty isoforms
of phosphoinositide kinases,
phosphatases and phospholipases
that modulate the level of
phosphoinositides to regulate
processes such as membrane
trafficking, cell survival, proliferation
and migration. Phosphoinositides
carry out their functions by regulating
the activity of proteins that harbour
specific phosphoinositide-interacting
modules (such as the PH, FYVE,
FERM, and PHOX domains) [2].
Phosphatidylinositol (4,5)
bisphosphate (PtdIns(4,5)P2) is one of
the busiest phosphoinositides, being
the substrate for receptor-activated
phospholipase C (PLC) and
phosphatidylinositol-3 kinase, as well
as having its own unique signalling
functions in plasma membrane
trafficking and actin polymerisation [1].
Furthermore, polarised synthesis
of PtdIns(4,5)P2 is important for the
maintenance of epithelial cell
morphology [3], podosome function,and membrane ruffling [4] and for
the first asymmetric cleavage after
fertilisation in Caenorhabditis
elegans [5]. How localised synthesis
of PtdIns(4,5)P2 is achieved is far from
clear. A new study into the role of
phosphoinositides in phagocytosis by
Grinstein and colleagues [6] has now
revealed that the plasma membrane
localisation of PIP5K is dependent on
the electrostatic interactions between
PIP5K and the negative surface of
the plasma membrane.
Phagocytosis is the major
mechanism by which apoptotic bodies
and foreign particles such as bacteria
are eliminated from the organism [7].
Opsonisation of the bacterial surface
promotes phagocytosis, leading to
the interaction of the bacteria with
specific cell-surface receptors on
macrophages. The ensuing pseudopod
formation extends the macrophage
plasma membrane around the
bacterium, eventually leading to
the isolation of the bacterium in an
intracellular membrane-bounded
vacuole (the phagosome). The
phagosome matures over time,
becoming acidic and rich in hydrolases
and anti-microbial agents capable
of degrading bacteria. In a series of
elegant studies the Grinstein laboratory
has previously demonstrated exquisite
spatial and temporal changes inphosphoinositides as the phagosome
forms and matures (for a review, see
[8]). Initially, upon cell surface binding
of the particle, there is an increase
in PtdIns(4,5)P2 [9] and then
PtdIns(3,4,5)P3 at the base of the
particle, which is maintained as the
pseudopods traverse around the
particle. The increased PtdIns(4,5)P2
accumulation probably helps to drive
actin polymerisation, which is required
for pseudopod extension. At the
point of engulfment and sealing,
the PtdIns(4,5)P2 at the base of
the phagosome — and only at the
base — dramatically decreases,
leading to actin depolymerisation
and sealing and internalisation of
the phagosome (Figure 1).
Interventions that compromise either
PtdIns(4,5)P2 synthesis or its
degradation also compromise
phagocytosis [10,11]. PIP5K isoforms
(a, b and g) phosphorylate PtdIns4P on
the 50 position and are responsible for
the synthesis of the majority of cellular
PtdIns(4,5)P2 [1]. During phagocytosis,
PIP5Kg is required for clustering
receptors that interact with bacteria,
while PIP5Ka regulates actin
polymerisation and bacterial
internalisation. PIP5Ka localises to the
forming phagosome [12] and, together
with PIP5Kg, probably increases
PtdIns(4,5)P2 in the pseudopods.
But how is the decrease in
PtdIns(4,5)P2 at the base of the
phagosome achieved? Increased
PtdIns(3,4,5)P3 synthesis is critical as
it can activate PLC-g, which hydrolyses
PtdIns(4,5)P2. However, although
PIP5Ka is targeted to the phagocytic
cup at early stages, it is lost just before
phagosome internalisation [11],
suggesting that reducing PtdIns(4,5)P2
synthesis may also be important in
